Back

Emergence and Evolution of a Prevalent New SARS-CoV-2 Variant in the United States

Pater, A. A.; Bosmeny, M. S.; Barkau, C. L.; Ovington, K. N.; Chilamkurthy, R.; Parasrampuria, M.; Eddington, S. B.; Yinusa, A. O.; White, A. A.; Metz, P. E.; Sylvain, R. J.; Hebert, M. M.; Benzinger, S. W.; Sinha, K. T.; Gagnon, K. T.

2021-01-13 genomics
10.1101/2021.01.11.426287 bioRxiv
Show abstract

Genomic surveillance can lead to early identification of novel viral variants and inform pandemic response. Using this approach, we identified a new variant of the SARS-CoV-2 virus that emerged in the United States (U.S.). The earliest sequenced genomes of this variant, referred to as 20C-US, can be traced to Texas in late May of 2020. This variant circulated in the U.S. uncharacterized for months and rose to recent prevalence during the third pandemic wave. It initially acquired five novel, relatively unique non-synonymous mutations. 20C-US is continuing to acquire multiple new mutations, including three independently occurring spike protein mutations. Monitoring the ongoing evolution of 20C-US, as well as other novel emerging variants, will be essential for understanding SARS-CoV-2 host adaptation and predicting pandemic outcomes.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.